Issue
An investigation of NIS expression in gastric tissue of obese individuals
Corresponding Author(s) : Deniz Mihcioglu
Cellular and Molecular Biology,
Vol. 64 No. 4: Issue 4
Abstract
Obesity is seen as one of the top ten (10) illness's listed by World Health Organization (WHO). It is a global problem that can affect people of all ages. Obesity is identified one of the most important factors leading to diabetes, heart disease and hypertension. Individuals with a Body Mass Index (BMI) above 40 kg/m2 are defined with morbid obesity. Sodium Iodide Symporter (NIS) gene is a plasma membrane glycoprotein that mediates iodide uptake in thyroid glands, stomach, salivary glands, lactating mammary glands and intestine. NIS gene transports iodide from the blood to the gastric epithelial cells. NIS gene expression and regulatory role of NIS gene in gastrointestinal tract, hasn't been studied yet in the individuals with obesity (i.e., BMI >40 kg/m2). In this study, gastric tissues were obtained by laparoscopic sleeve gastrectomy from 33 individuals diagnosed with obesity. Control group consisted of gastric tissue of 21 subjects with normal BMI obtained by endoscopy. RNA isolation, cDNA synthesis and qRT-PCR analyses were performed on the samples to determine NIS gene expression. Expression levels of NIS gene were compared between obese and control individuals, although an increase was observed in obese patients this difference was not found to be statistically important (p>0.05).
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- James WP. The epidemiology of obesity: the size of the problem. J Intern Med. Apr 2008; 263(4): 336-352.
- Chen L, Tuo B, Dong H. Regulation of intestinal glucose absorption by ion channels and transporters. Nutrients. 2016; 8(1): 43.
- Hamzeh N, Ghadimi F, Farzaneh R, Hosseini SK. Obesity, Heart Failure, and Obesity Paradox. The Journal of Tehran University Heart Center. 2017; 12(1): 1.
- Poirier P, Alpert MA, Fleisher LA et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery. Circulation. 2009; 120(1): 86-95.
- Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM cardiovascular disease. 2016; 5: 2048004016633371.
- Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Annals of translational medicine. 2017; 5(7).
- Ali AT, Hochfeld WE, Myburgh R, Pepper MS. Adipocyte and adipogenesis. European journal of cell biology. 2013; 92(6): 229-236.
- Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. The American journal of clinical nutrition. 2006; 83(2): 461S-465S.
- Gray SL, Vidal-Puig AJ. Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutrition reviews. 2007; 65(suppl_1): S7-S12.
- Vasconcelos LH, Souza IL, Pinheiro LS, Silva BA. Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets. Frontiers in pharmacology. 2016; 7.
- Sohn J-W. Ion channels in the central regulation of energy and glucose homeostasis. Frontiers in neuroscience. 2013; 7.
- Dohan O, De la Vieja A, Paroder V et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine reviews. 2003; 24(1): 48-77.
- Filetti S, Bidart J-M, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. European Journal of Endocrinology. 1999; 141(5): 443-457.
- Darrouzet E, Lindenthal S, Marcellin D, Pellequer J-L, Pourcher T. The sodium/iodide symporter: state of the art of its molecular characterization. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2014; 1838(1): 244-253.
- Dohán O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. The Na+/I− symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proceedings of the National Academy of Sciences. 2007; 104(51): 20250-20255.
- Bravo-Sagua R, Mattar P, Díaz X, Lavandero S, Cifuentes M. Calcium sensing receptor as a novel mediator of adipose tissue dysfunction: mechanisms and potential clinical implications. Frontiers in physiology. 2016; 7.
- Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I− symporter (NIS): mechanism and medical impact. Endocrine reviews. 2013; 35(1): 106-149.
- Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N. The Na+/I− symporter mediates active iodide uptake in the intestine. American Journal of Physiology-Cell Physiology. 2009; 296(4): C654-C662.
- Spitzweg C, Joba W, Eisenmenger W, Heufelder A. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. The Journal of Clinical Endocrinology & Metabolism. 1998; 83(5): 1746-1751.
- Bizhanova A, Kopp P. The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology. 2009; 150(3): 1084-1090.
- Sodhi K, Maxwell K, Yan Y et al. pNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis. Science advances. 2015; 1(9): e1500781.
- Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na, K-ATPase in obesity and diabetes: a new proposed enzyme regulation. The American journal of the medical sciences. 2007; 333(1): 1-9.
- Illison J, Tian L, McClafferty H et al. Obesogenic and diabetogenic effects of high-calorie nutrition require adipocyte BK channels. Diabetes. 2016; 65(12): 3621-3635.
- Laskowski M, Andersson C, Eliasson E, Golubinskaya V, Nilsson H. Potassium-Channel-Independent Relaxing Influence of Adipose Tissue on Mouse Carotid Artery. Journal of Vascular Research. 2017; 54(1): 51-57.
- Ka H, Han S, Jeong A et al. Neuronatin Is Associated with Anti-Inflammatory Role in the White Adipose Tissue. Journal of microbiology and biotechnology. 2017.
- Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annual review of immunology. 2011; 29: 415-445.
- Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cellular and molecular life sciences. 2014; 71(6): 1033-1043.
- Shen DH, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease. Thyroid. 2001; 11(5): 415-425.
- Gorboulev V, Schürmann A, Vallon V et al. Na+-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012; 61(1): 187-196.
- Altorjay í, Dohán O, Szilágyi A, Paroder M, Wapnir IL, Carrasco N. Expression of the Na+/l-symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus. BMC cancer. 2007; 7(1): 5.
- Tazebay UH, Wapnir IL, Levy O et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature medicine. 2000; 6(8): 871-878.
- Zhang R, Wang H, Zhao J et al. Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies. International journal of clinical and experimental medicine. 2015; 8(10): 17986.
- Longhi S, Radetti G. Thyroid function and obesity. Journal of clinical research in pediatric endocrinology. 2013; 5(Suppl 1): 40.
References
James WP. The epidemiology of obesity: the size of the problem. J Intern Med. Apr 2008; 263(4): 336-352.
Chen L, Tuo B, Dong H. Regulation of intestinal glucose absorption by ion channels and transporters. Nutrients. 2016; 8(1): 43.
Hamzeh N, Ghadimi F, Farzaneh R, Hosseini SK. Obesity, Heart Failure, and Obesity Paradox. The Journal of Tehran University Heart Center. 2017; 12(1): 1.
Poirier P, Alpert MA, Fleisher LA et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery. Circulation. 2009; 120(1): 86-95.
Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM cardiovascular disease. 2016; 5: 2048004016633371.
Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Annals of translational medicine. 2017; 5(7).
Ali AT, Hochfeld WE, Myburgh R, Pepper MS. Adipocyte and adipogenesis. European journal of cell biology. 2013; 92(6): 229-236.
Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. The American journal of clinical nutrition. 2006; 83(2): 461S-465S.
Gray SL, Vidal-Puig AJ. Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutrition reviews. 2007; 65(suppl_1): S7-S12.
Vasconcelos LH, Souza IL, Pinheiro LS, Silva BA. Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets. Frontiers in pharmacology. 2016; 7.
Sohn J-W. Ion channels in the central regulation of energy and glucose homeostasis. Frontiers in neuroscience. 2013; 7.
Dohan O, De la Vieja A, Paroder V et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine reviews. 2003; 24(1): 48-77.
Filetti S, Bidart J-M, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. European Journal of Endocrinology. 1999; 141(5): 443-457.
Darrouzet E, Lindenthal S, Marcellin D, Pellequer J-L, Pourcher T. The sodium/iodide symporter: state of the art of its molecular characterization. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2014; 1838(1): 244-253.
Dohán O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. The Na+/I− symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proceedings of the National Academy of Sciences. 2007; 104(51): 20250-20255.
Bravo-Sagua R, Mattar P, Díaz X, Lavandero S, Cifuentes M. Calcium sensing receptor as a novel mediator of adipose tissue dysfunction: mechanisms and potential clinical implications. Frontiers in physiology. 2016; 7.
Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I− symporter (NIS): mechanism and medical impact. Endocrine reviews. 2013; 35(1): 106-149.
Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N. The Na+/I− symporter mediates active iodide uptake in the intestine. American Journal of Physiology-Cell Physiology. 2009; 296(4): C654-C662.
Spitzweg C, Joba W, Eisenmenger W, Heufelder A. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. The Journal of Clinical Endocrinology & Metabolism. 1998; 83(5): 1746-1751.
Bizhanova A, Kopp P. The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology. 2009; 150(3): 1084-1090.
Sodhi K, Maxwell K, Yan Y et al. pNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis. Science advances. 2015; 1(9): e1500781.
Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na, K-ATPase in obesity and diabetes: a new proposed enzyme regulation. The American journal of the medical sciences. 2007; 333(1): 1-9.
Illison J, Tian L, McClafferty H et al. Obesogenic and diabetogenic effects of high-calorie nutrition require adipocyte BK channels. Diabetes. 2016; 65(12): 3621-3635.
Laskowski M, Andersson C, Eliasson E, Golubinskaya V, Nilsson H. Potassium-Channel-Independent Relaxing Influence of Adipose Tissue on Mouse Carotid Artery. Journal of Vascular Research. 2017; 54(1): 51-57.
Ka H, Han S, Jeong A et al. Neuronatin Is Associated with Anti-Inflammatory Role in the White Adipose Tissue. Journal of microbiology and biotechnology. 2017.
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annual review of immunology. 2011; 29: 415-445.
Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cellular and molecular life sciences. 2014; 71(6): 1033-1043.
Shen DH, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease. Thyroid. 2001; 11(5): 415-425.
Gorboulev V, Schürmann A, Vallon V et al. Na+-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012; 61(1): 187-196.
Altorjay í, Dohán O, Szilágyi A, Paroder M, Wapnir IL, Carrasco N. Expression of the Na+/l-symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus. BMC cancer. 2007; 7(1): 5.
Tazebay UH, Wapnir IL, Levy O et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature medicine. 2000; 6(8): 871-878.
Zhang R, Wang H, Zhao J et al. Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies. International journal of clinical and experimental medicine. 2015; 8(10): 17986.
Longhi S, Radetti G. Thyroid function and obesity. Journal of clinical research in pediatric endocrinology. 2013; 5(Suppl 1): 40.